|
 |
 |
|
Peter joined Connecticut Innovations in 1995. He manages CI’s array of initiatives, including its venture capital investments, laboratory infrastructure fund and support service initiatives. Under his leadership, CI introduced the Pre-Seed Support Services Program, Connecticut Clean Tech Fund and CTech, an entrepreneurial assistance initiative. Additionally, Peter oversees the administration of the ratepayer-funded Connecticut Clean Energy Fund.
Peter has invested in over 20 early-stage investment opportunities across a variety of technology sectors, leading CI investments in Achillion Pharmaceuticals, CYA Technologies, Nufern, Perimeter eSecurity, Post-N-Track and Transaction Methods. He serves on the boards of CYA Technologies, ExeCue, Optiwind and Post-N-Track. He is a board observer of Perimeter eSecurity and Transaction Methods.
In addition, Peter serves on the advisory board of the University of Connecticut School of Engineering.
Prior to being named president and executive director of CI in 2007, Peter was a member of CI’s investment team and most recently was chief investment officer for CI. He also previously served as controller of CI before he joined the investment team.
Peter is a certified public accountant and a chartered financial analyst. He earned a bachelor's degree in business administration from the University of Connecticut and holds a master's degree in business administration from the University of Hartford. Peter also served six years in the Connecticut Army National Guard.
|
 |
|
Kevin joined Connecticut Innovations in 2006. He has led CI’s investments in Cara Therapeutics and Oil Purifications Systems. Kevin serves on the boards of frevvo, Oil Purification Systems, RemoTV and Retail Optimization and is a board observer for Cara Therapeutics. Additionally, Kevin manages the $46 million Connecticut BioScience Facilities Fund, which invests in the build-out of wet laboratory space.
Prior to joining CI, Kevin was director of the Office of BioScience at the Connecticut Department of Economic and Community Development (DECD), where he was responsible for bioscience business recruitment, client interaction, bioscience related public policy strategy and day-to-day operations of the office. He also previously served as director of business recruitment in DECD's Business Recruitment and Industry Clusters Division, negotiating relocation incentive packages for both large and small corporate development projects.
Kevin holds a Master of Business Administration degree from Quinnipiac University.
|
 |
|
Pauline joined Connecticut Innovations in 2002. Pauline has led CI’s investments in Environmental Energy Services, FMP Products, New Ortho Polymers, Premise Corporation and XLerant. She serves on the boards of Environmental Energy Services, FMP Products, ShopText, New Ortho Polymers and Xlerant is a board observer of CGI Pharmaceuticals. In addition to being responsible for initiating and closing deals, Pauline manages the investment associates and investment team support staff.
Pauline joined CI with over ten years of experience in both manufacturing and service organizations. She was controller of an early-stage software development company and launched her career at Ernst & Young, LLP.
She graduated magna cum laude with a bachelor's degree in accounting from the University of Connecticut and is a registered certified public accountant in the state of Connecticut
|
 |
|
Patrick joined Connecticut Innovations in 2006. His focus is in the area of clean technology and,with expertise gained while part of the Connecticut Clean Energy Fund team, he is now helping to launch and manage the new Connecticut Clean Tech Fund. Patrick is a board observer of Acumentrics, Optiwind, one of the first companies to receive an investment through the Connecticut Clean Tech Fund, and SmartEquip.
Prior to joining CI’s investment team, Patrick was a project manager for the Connecticut Clean Energy Fund’s On-Site Renewable Distributed Generation Program and Project 100. In this role, Patrick performed financial analysis on numerous renewable energy projects that utilized diverse technologies including fuel cell, solar photovoltaic, hydro and sustainable biomass. Previously, Patrick worked for UTC Power, Duke Engineering and Services (now Areva NP Inc.) and Yankee Atomic Electric Corporation.
Patrick holds a master's degree in business administration from New York University's Stern School of Business, a master's degree in mechanical engineering from Worcester Polytechnic Institute and a Bachelor of Science degree in nuclear engineering from the University of Massachusetts at Lowell. Additionally, Patrick is a licensed professional engineer in the state of Connecticut.
|  |
|
Matt joined Connecticut Innovations in 2005. His focus has been primarily in the area of bioscience. He led CI’s investments in SPOC and Standing Stone and serves on the boards of LegiTime Technologies, Retail Optimization, SPOC, and Standing Stone. He also serves on the board of the Connecticut Venture Group.
Matt came to CI with broad-based experience in the life science, medical device and healthcare arenas. He was a co-founder of CompreMedx Cancer Centers Corporation and Health Excel Management, both healthcare services companies, and was a co-owner of Kramex Corporation, a radiology equipment supplier. Matt also served on the board of directors and in senior management capacities for a variety of venture-backed bioscience companies, including companies involved in robotics, healthcare services and medical devices. Additionally, he made venture capital investments in medical device companies while at GTE New Ventures Corporation.
Matt has also shared his business experiences in an academic setting, having served as the first executive director of the Entrepreneurship and Small Business Management Institute at Quinnipiac University and as an adjunct member of the Quinnipiac University School of Business faculty. He also was a member of the faculty of the Albert Einstein College of Medicine of Yeshiva University, where he co-authored the first federally funded HMO feasibility study.
Matt holds both a bachelor's degree and a Master of Business Administration degree from Boston University.
|  |
|
Russell has been with Connecticut Innovations and its predecessor organization since 1985. Over the past 20 years, he has invested in more than 50 companies. He has led CI’s investments in bioscience companies including Affomix Corporation, Cardiopulmonary Corporation, Genaissance Pharmaceuticals and Ipsogen Inc. He also led CI’s investment in I-Mark. He serves on the board of Ipsogen Inc. and is also a board observer of Ipsogen SA, parent of Ipsogen Inc., and Affomix.
Seven of the current or former CI portfolio companies that Russell invested in have had successful initial public offerings: Achillion Pharmaceuticals, BioPlexus, Genaissance Pharmaceuticals, Ipsogen, International Telecommunication Data Systems (ITDS), Open Solutions and Proton Energy Systems. Additionally, two of the companies in which he invested were acquired: Cardium Health Services (acquired by Centene Corporation) and Genaissance Pharmaceuticals (acquired by Clinical Data).
Russell came to CI with over 25 years of experience in economic and venture analysis, engineering cost accounting, systems analysis, scientific and commercial programming, math analysis, EDP auditing and computer modeling. He was previously with Scientific Leasing, the Robert E. Nolan Co. and United Technologies Corp.
Russ holds a Bachelor of Science Degree in electrical engineering and a Master of Business Administration degree from the University of Hartford.
|  |
|
Anil joined Connecticut Innovations in 2007. His focus has been in the area of information technology. Anil led CI’s investment in ExeCue, helping to relocate the company from New York to Connecticut. He serves on the boards of ExeCue and Continuity Engine and is a board observer at Acumentrics.
Anil came to CI with more than ten years of experience in business strategy, operations, finance and business development in Fortune 500 high-technology and communications companies. As a senior consultant at IBM, Anil evaluated investment opportunities in new technologies and worked on engagements to streamline business operations. As a manager at Oracle, Anil led product development initiatives and solution implementation teams for several client engagements. Anil also worked as a summer associate at TL Ventures, conducting IT industry research. Additionally, he served as an intern with the video and media engineering group of Comcast Corporation, where he conducted market research on alternate multicasting platforms and evaluated new technologies for increasing broadcast bandwidth.
Anil earned a Bachelor of Engineering degree in chemical engineering from Regional Engineering College, Durgapur, India, and a Master of Business Administration degree from The Wharton School at the University of Pennsylvania.
|
 |
|
Dan joined Connecticut Innovations in 2007 and is responsible for evaluating investment opportunities, structuring new investments and monitoring portfolio companies. He has been involved in CI’s investments in Cara Therapeutics, FMP Products, Helix Therapeutics, ShopText and Soft Tissue Regeneration. Dan serves as a board observer for eNR Services, FMP Products, Helix Therapeutics, Rib-X Pharmaceuticals, ShopText and Soft Tissue Regeneration. Dan also helps to administer Connecticut’s $100 million Stem Cell Research Fund in partnership with the Connecticut Department of Public Health.
Dan came to CI with over ten years of experience in the Connecticut biotech arena. He was previously employed by CuraGen Corporation, a successful former CI portfolio company. While at CuraGen, Dan held a variety of scientific and operational management positions. His extensive experience in research and development, technology assessment, and implementation of next generation scientific technologies enabled Dan to help transform CuraGen from a genomic and proteomic platform company into a biopharmaceutical firm dedicated to advancing its protein, antibody and small molecule therapeutics.
Dan holds a Bachelor of Science degree in biology from the University of Dayton and earned both Master of Business Administration and Master of Health Sciences degrees from Quinnipiac University.
|
 |
|
Dave joined Connecticut Innovations in 2009. He is responsible for sourcing and analyzing investment opportunities, leading CI investments in entrepreneurial high-tech ventures, and advising portfolio companies.
Dave came to CI with extensive senior-level experience in operations and finance. Most recently, he was executive vice president, treasurer and chief financial officer of CuraGen Corporation (NASDAQ: CRGN), a former CI portfolio company. Dave guided the biotech company through its initial public offering and helped raise over $700 million for the company. Dave was also involved in negotiating strategic and business development alliances with several pharmaceutical and biotech companies, including Roche, Bayer, and Amgen-Freemont (Abgenix). He helped to grow CuraGen and its technology development subsidiary into an operation with over 500 employees and a market capitalization as high as $5.3 billion.
Previously, Dave served as senior vice president, treasurer and chief financial officer of Value Health Inc. (NYSE:VH), a specialty managed health care company. He helped the company achieve exceptional growth, actively participating in multiple acquisitions and public offerings and the sale of the company to Columbia/HCA for $1.1 billion.
Dave began his professional career with Coopers & Lybrand in Hartford, Conn. (now part of PricewaterhouseCoopers), where he held various accounting and managerial positions.
He is a certified public accountant and holds a Bachelor of Business Administration in Accountancy degree from the University of Notre Dame. |
|
 |
 |
|
Heidi joined Connecticut Innovations in 1995. She is the administrative assistant to the president of CI, vice president of finance and administration, chairman of the board and investment team. Previously, she assisted the president of the Connecticut Clean Energy Fund and CCEF’s staff. When she joined CI, Heidi assisted the investment team of CI as its secretary. Before joining CI, Heidi worked for eight years as an administrative assistant at Education & Training Programs (ETP). Prior to that, she worked for Wetzel Tool and Joseph H. Bertram & Co. Heidi attended Manchester Community College and Hartford College for Women.
|
 |
|
Stepheni has been with Connecticut Innovations since 1992. She helps with the due diligence process and assists the investment team. Stepheni joined the investment team in 1999 as an investment analyst, screening inquiries and tracking the progress of potential investment clients. Previously, she served as finance associate, responsible for legislative reporting and investment tracking.
Prior to joining CI, Stepheni worked for several years in retail management and law firm administration. Stepheni holds a bachelor's degree in business management and human resource development from the University of Connecticut as well as a master's degree in business administration from the University of Hartford.
|
 |
|
Julie joined Connecticut Innovations in 1993. She is responsible for analyzing new investment opportunities, assisting the investment team with due diligence and tracking the progress of investment candidates. Julie also maintains CI’s information resources.
Julie came to CI with 15 years of experience as a media specialist in the Connecticut school system and in public libraries. She earned a bachelor’s degree from the College of St. Theresa, Kansas City, and took graduate-level courses in library science at Southern Connecticut State University.
|
|
|
|
|
